Research Institute of Dallas
- World rank, all time
- #28,001 of 42,892
- Rank in United States
- #6,010 of 8,685
- Research works
- 121 ▲ 200% vs 2013–17
- Citations
- 2.9k 23.8 per fractional work
- Top-10% rate
- 27.1% record average 16.5%
- Open access
- 40% world 28%
What does Research Institute of Dallas specialise in?
Where its research is concentrated relative to its size: Medicine takes 3.8× the share of its output that it takes of world research.
- MedicineField · 30.2 works3.8×
Location quotient, a volume reading rather than an impact one. It surfaces small, lopsided specialities.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Immunology and Microbiology, 4.4×. Every wedge is a field page.
- Immunology and Microbiology 4.4×
- Medicine 3.8×
- Biochemistry, Genetics and Molecular Biology 1.2×
- Environmental Science 1.2×
- Nursing 0.8×
- Health Professions 0.6×
- Economics, Econometrics and Finance 0.5×
- Neuroscience 0.4×
- Agricultural and Biological Sciences 0.4×
- Mathematics 0.3×
- Engineering 0.2×
- Computer Science 0.2×
- Pharmacology, Toxicology and Pharmaceutics 0.2×
- Psychology 0.1×
- Social Sciences 0.0×
Which keywords describe research at Research Institute of Dallas?
By fractional works in 2022–2025, weighted toward what it does more of than the world: Heart Failure, Cardiovascular Disease, Lymphoma, Immunotherapy, Cancer Immunotherapy, CAR T Cells, Chimeric Antigen Receptor and Guidelines.
- Endothelial Dysfunction
- Risk Factors
- Machine Learning
- Diabetes Mellitus
- Cardiovascular Outcomes
- Renal Function
- Hospital Readmission
- Type 2 Diabetes
- Glycemic Control
- Diagnosis
- Inflammation
- Oxidative Stress
- Chimeric Antigen Receptor
- Cancer Immunotherapy
- Immunotherapy
- Cardiovascular Disease
- Heart Failure
- Epidemiology
- Lymphoma
- CAR T Cells
- Guidelines
- Treatment
- Clinical Guidelines
- Echocardiography
- Insulin Therapy
- B-Type Natriuretic Peptide
- Obesity
- Tumor Microenvironment
- Glucose Control
- Invasive Species
- Quality of Life
- Cognitive Impairment
- Metabolic Syndrome
Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 33 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 33 words, with their numbers
- Heart Failure5▲ 30×11 topics
- Cardiovascular Disease4▲ 8.7×20 topics
- Epidemiology4▲ 2.5×30 topics
- Immunotherapy3▲ 9.3×5 topics
- Lymphoma3▲ 42×2 topics
- Cancer Immunotherapy3▲ 43×2 topics
- CAR T Cells2▲ 81×1 topic
- Chimeric Antigen Receptor2▲ 81×1 topic
- Guidelines2▲ 13×8 topics
- Oxidative Stress2▲ 3.3×12 topics
- Treatment2▲ 4.2×7 topics
- Inflammation2▲ 2.3×19 topics
- Clinical Guidelines2▲ 15×3 topics
- Diagnosis2▲ 5.0×5 topics
- Echocardiography2▲ 16×4 topics
- Glycemic Control2▲ 28×3 topics
- Insulin Therapy2▲ 36×3 topics
- Type 2 Diabetes2▲ 19×4 topics
- B-Type Natriuretic Peptide2▲ 79×1 topic
- Hospital Readmission2▲ 79×1 topic
- Obesity2▲ 5.0×10 topics
- Renal Function2▲ 41×2 topics
- Tumor Microenvironment2▲ 8.8×4 topics
- Cardiovascular Outcomes2▲ 66×1 topic
- Glucose Control2▲ 66×1 topic
- Diabetes Mellitus1▲ 15×4 topics
- Invasive Species1▲ 6.3×3 topics
- Machine Learning1▼ 0.77×4 topics
- Quality of Life1▲ 1.80×10 topics
- Risk Factors1▲ 2.3×8 topics
- Cognitive Impairment1▲ 9.8×2 topics
- Endothelial Dysfunction1▲ 11×4 topics
- Metabolic Syndrome1▲ 3.0×10 topics
Which research topics does Research Institute of Dallas publish most on?
By volume in 2022–2025: CAR-T cell therapy research, Heart Failure Treatment and Management, Diabetes Treatment and Management and Cancer Immunotherapy and Biomarkers.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 CAR-T cell therapy research Oncology 2 works
- 2 Heart Failure Treatment and Management Cardiology and Cardiovascular Medicine 2 works
- 3 Diabetes Treatment and Management Endocrinology, Diabetes and Metabolism 2 works
- 4 Cancer Immunotherapy and Biomarkers Oncology 1 works
- 5 Cardiac Valve Diseases and Treatments Cardiology and Cardiovascular Medicine 1 works
- 6 Folate and B Vitamins Research Rheumatology 1 works
- 7 Cardiovascular Function and Risk Factors Cardiology and Cardiovascular Medicine 1 works
- 8 Immune Cell Function and Interaction Immunology 1 works
- 9 Pancreatic function and diabetes Surgery 1 works
- 10 Stroke Rehabilitation and Recovery Rehabilitation 1 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Research Institute of Dallas's research output changed?
Output in 2018–2022 was 200% higher than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Dallas
- The University of Texas Southwestern Medical Center
- Southern Methodist University
- Texas Instruments (United States)
- Baylor University Medical Center
- Lung Institute
- University of Texas Health Science Center at Dallas
- Jacobs (United States)
- Texas Health Dallas
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.